Carlos Caldas

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Data from PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2− Breast Cancer: Clinical and Circulating Tumor DNA Results

  2026-06-17

• Supplementary Data1 from PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2− Breast Cancer: Clinical and Circulating Tumor DNA Results

  2026-06-17

• Differences and challenges in collaborative risk management across different project delivery methods

  Engineering Construction & Architectural Management · 2026-05-25

• Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cells

  Cell Reports Methods · 2026-05-01

• Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancer.

  Apollo (University of Cambridge) · 2026-02-20

• Supplemental Materials

  Zenodo (CERN European Organization for Nuclear Research) · 2026-01-01

• Supplemental Materials

  Zenodo (CERN European Organization for Nuclear Research) · 2026-01-01

• Data from eQTL Set–Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma

  2025-11-26

• Supplementary Figure from eQTL Set–Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma

  2025-11-26

• The tumor microenvironment of 14,837 breast cancers is associated with clinical outcome independently of genomic subtypes

  Cell Reports Medicine · 2025-11-01

• 1086 Enhanced prediction of chemotherapy response in breast cancer via integrating deconvolved expression patterns of immune, stromal and tumor cells in tumor microenvironment

  Regular and Young Investigator Award Abstracts · 2025-11-01

• Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells

  Cancer Letters · 2025-10-30

• Abstract B047: Path2Space: An AI approach for cancer biomarker discovery via histopathology inferred spatial transcriptomics

  Clinical Cancer Research · 2025-07-10

• Supplementary Table S2 from Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

  2025-06-03

• Supplementary Table S1 from Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

  2025-06-03

• Supplementary Figure S1 from Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled AnalysisPreprint

  2025-06-03

• Supplementary Table S4 from Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

  2025-06-03

• Supplementary Figure S2 from Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled AnalysisPreprint

  2025-06-03

• Supplementary Table S6 from Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

  2025-06-03

• Supplementary Table S9 from Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

  2025-06-03